Pulse Biosciences Balance Sheet
NASDAQ: PLSEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pulse Biosciences financial position
At the end of fiscal 2025, Pulse Biosciences reported total assets of $94.5 million, down 28.6% from a year earlier against total liabilities of $13.9 million. Shareholders' equity stood at $80.7 million, or 85.3% of assets. The company held $80.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 10.53, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Pulse Biosciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 80.73M | 118.04M | 44.37M | 61.14M | 44.37M | 12.46M | 6.90M | 51.10M | 3.39M | 2.09M |
| Short-Term Investments | — | — | — | — | — | 8.01M | 18.50M | 8.48M | 34.68M | 14.31M |
| Receivables | 274.00K | 0 | — | 0 | 61.00K | — | — | — | — | — |
| Inventory | 136.00K | 0 | — | 0 | 5.82M | — | — | — | — | — |
| Total Current Assets | 83.42M | 119.45M | 45.33M | 62.15M | 45.33M | 22.34M | 26.40M | 60.36M | 38.48M | 16.66M |
| Property, Plant & Equipment | 1.05M | 1.16M | 1.53M | 1.96M | 1.53M | 2.48M | 2.57M | 2.17M | 2.57M | 317.00K |
| Goodwill | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
| Intangible Assets | 575.00K | 1.22M | 1.89M | 2.55M | 1.89M | 3.88M | 4.55M | 5.21M | 5.88M | 6.54M |
| Total Assets | 94.54M | 132.46M | 59.15M | 77.88M | 59.15M | 41.29M | 41.91M | 70.64M | 49.82M | 26.31M |
| Accounts Payable | 2.78M | 1.67M | 1.84M | 1.57M | 1.84M | 1.72M | 1.96M | 1.27M | 782.00K | 265.00K |
| Total Current Liabilities | 7.92M | 10.05M | 6.71M | 5.98M | 6.71M | 7.58M | 4.46M | 3.11M | 2.21M | 1.02M |
| Long-Term Debt | — | — | 0 | 65.00M | — | — | — | — | — | — |
| Total Liabilities | 13.88M | 17.60M | 14.79M | 80.13M | 14.79M | 18.40M | 11.18M | 4.31M | 3.83M | 1.02M |
| Shareholders' Equity | 80.66M | 114.86M | 44.36M | -2.25M | 44.36M | 22.89M | 30.74M | 66.33M | 45.99M | 25.30M |
| Retained Earnings | -463.28M | -390.50M | -336.92M | -294.70M | -336.92M | -172.54M | -122.69M | -75.72M | -38.17M | -12.61M |
| Total Debt | — | — | 0 | 65.00M | — | — | — | — | — | — |
| Net Cash (Debt) | 80.73M | 118.04M | 44.37M | -3.86M | 44.37M | 20.48M | 25.40M | 59.58M | 38.07M | 16.39M |
| Shares Outstanding | 67.84M | 65.93M | 55.14M | 37.23M | 55.14M | 25.55M | 20.82M | 20.59M | 16.82M | 13.31M |
This table shows 10 annual periods of Pulse Biosciences's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PLSE's reporting calendar. What is a balance sheet?